NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR TREATMENT OF DISEASES

The present invention discloses compounds according to Formula (I), wherein R1a, R1b, R1c, R2a, W1, W2, X1, X2, X3, Y, and Z are as defined herein. The present invention relates to compounds, methods for their production, pharmaceutical compositions comprising the same, and methods of treatment usin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: DUTHION BERANGER, ALVEY LUKE, TIRERA AMYNATA, BONNATERRE FLORENCE, BUCHER DENIS, JARY HELENE M, DESROY NICOLAS, PEIXOTO CHRISTOPHE, TEMAL-LAIB TAOUES
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator DUTHION BERANGER
ALVEY LUKE
TIRERA AMYNATA
BONNATERRE FLORENCE
BUCHER DENIS
JARY HELENE M
DESROY NICOLAS
PEIXOTO CHRISTOPHE
TEMAL-LAIB TAOUES
description The present invention discloses compounds according to Formula (I), wherein R1a, R1b, R1c, R2a, W1, W2, X1, X2, X3, Y, and Z are as defined herein. The present invention relates to compounds, methods for their production, pharmaceutical compositions comprising the same, and methods of treatment using the same, for the prophylaxis and/or treatment of inflammatory diseases, autoinflammatory diseases, autoimmune diseases, proliferative diseases, fibrotic diseases, transplantation rejection, diseases involving impairment of cartilage turnover, congenital cartilage malformation, diseases involving impairment of bone turnover, diseases associated with hypersecretion of IL-6, diseases associated with hypersecretion of TNF alpha, interferons, IL-12 and/or IL-23, respiratory diseases, endocrine and/or metabolic diseases, cardiovascular diseases, dermatological diseases, and/or abnormal angiogenesis associated diseases by administering the compound of the invention. 本发明公开了式(I)的化合物,其中R1a、R1b、R1c、R2a、W1、W2、X1、X2、X3、Y和Z如本
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN113924146A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN113924146A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN113924146A3</originalsourceid><addsrcrecordid>eNqNikEKwjAQAHPxIOof1gd4iC2CxyXZkIDZ1GTrtRSJJ9FC_T966AM8DczMWl053egCJsUu9WwLIFvoPOaIhnoJBpdYgoTEBcRTpuTApQySCSUSC_yEDYWwUNmq1WN8znW3cKP2jsT4Q53eQ52n8V5f9TMY1ro5H1vdnrD55_kCzREvnQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR TREATMENT OF DISEASES</title><source>esp@cenet</source><creator>DUTHION BERANGER ; ALVEY LUKE ; TIRERA AMYNATA ; BONNATERRE FLORENCE ; BUCHER DENIS ; JARY HELENE M ; DESROY NICOLAS ; PEIXOTO CHRISTOPHE ; TEMAL-LAIB TAOUES</creator><creatorcontrib>DUTHION BERANGER ; ALVEY LUKE ; TIRERA AMYNATA ; BONNATERRE FLORENCE ; BUCHER DENIS ; JARY HELENE M ; DESROY NICOLAS ; PEIXOTO CHRISTOPHE ; TEMAL-LAIB TAOUES</creatorcontrib><description>The present invention discloses compounds according to Formula (I), wherein R1a, R1b, R1c, R2a, W1, W2, X1, X2, X3, Y, and Z are as defined herein. The present invention relates to compounds, methods for their production, pharmaceutical compositions comprising the same, and methods of treatment using the same, for the prophylaxis and/or treatment of inflammatory diseases, autoinflammatory diseases, autoimmune diseases, proliferative diseases, fibrotic diseases, transplantation rejection, diseases involving impairment of cartilage turnover, congenital cartilage malformation, diseases involving impairment of bone turnover, diseases associated with hypersecretion of IL-6, diseases associated with hypersecretion of TNF alpha, interferons, IL-12 and/or IL-23, respiratory diseases, endocrine and/or metabolic diseases, cardiovascular diseases, dermatological diseases, and/or abnormal angiogenesis associated diseases by administering the compound of the invention. 本发明公开了式(I)的化合物,其中R1a、R1b、R1c、R2a、W1、W2、X1、X2、X3、Y和Z如本</description><language>chi ; eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220111&amp;DB=EPODOC&amp;CC=CN&amp;NR=113924146A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220111&amp;DB=EPODOC&amp;CC=CN&amp;NR=113924146A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DUTHION BERANGER</creatorcontrib><creatorcontrib>ALVEY LUKE</creatorcontrib><creatorcontrib>TIRERA AMYNATA</creatorcontrib><creatorcontrib>BONNATERRE FLORENCE</creatorcontrib><creatorcontrib>BUCHER DENIS</creatorcontrib><creatorcontrib>JARY HELENE M</creatorcontrib><creatorcontrib>DESROY NICOLAS</creatorcontrib><creatorcontrib>PEIXOTO CHRISTOPHE</creatorcontrib><creatorcontrib>TEMAL-LAIB TAOUES</creatorcontrib><title>NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR TREATMENT OF DISEASES</title><description>The present invention discloses compounds according to Formula (I), wherein R1a, R1b, R1c, R2a, W1, W2, X1, X2, X3, Y, and Z are as defined herein. The present invention relates to compounds, methods for their production, pharmaceutical compositions comprising the same, and methods of treatment using the same, for the prophylaxis and/or treatment of inflammatory diseases, autoinflammatory diseases, autoimmune diseases, proliferative diseases, fibrotic diseases, transplantation rejection, diseases involving impairment of cartilage turnover, congenital cartilage malformation, diseases involving impairment of bone turnover, diseases associated with hypersecretion of IL-6, diseases associated with hypersecretion of TNF alpha, interferons, IL-12 and/or IL-23, respiratory diseases, endocrine and/or metabolic diseases, cardiovascular diseases, dermatological diseases, and/or abnormal angiogenesis associated diseases by administering the compound of the invention. 本发明公开了式(I)的化合物,其中R1a、R1b、R1c、R2a、W1、W2、X1、X2、X3、Y和Z如本</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNikEKwjAQAHPxIOof1gd4iC2CxyXZkIDZ1GTrtRSJJ9FC_T966AM8DczMWl053egCJsUu9WwLIFvoPOaIhnoJBpdYgoTEBcRTpuTApQySCSUSC_yEDYWwUNmq1WN8znW3cKP2jsT4Q53eQ52n8V5f9TMY1ro5H1vdnrD55_kCzREvnQ</recordid><startdate>20220111</startdate><enddate>20220111</enddate><creator>DUTHION BERANGER</creator><creator>ALVEY LUKE</creator><creator>TIRERA AMYNATA</creator><creator>BONNATERRE FLORENCE</creator><creator>BUCHER DENIS</creator><creator>JARY HELENE M</creator><creator>DESROY NICOLAS</creator><creator>PEIXOTO CHRISTOPHE</creator><creator>TEMAL-LAIB TAOUES</creator><scope>EVB</scope></search><sort><creationdate>20220111</creationdate><title>NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR TREATMENT OF DISEASES</title><author>DUTHION BERANGER ; ALVEY LUKE ; TIRERA AMYNATA ; BONNATERRE FLORENCE ; BUCHER DENIS ; JARY HELENE M ; DESROY NICOLAS ; PEIXOTO CHRISTOPHE ; TEMAL-LAIB TAOUES</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN113924146A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>DUTHION BERANGER</creatorcontrib><creatorcontrib>ALVEY LUKE</creatorcontrib><creatorcontrib>TIRERA AMYNATA</creatorcontrib><creatorcontrib>BONNATERRE FLORENCE</creatorcontrib><creatorcontrib>BUCHER DENIS</creatorcontrib><creatorcontrib>JARY HELENE M</creatorcontrib><creatorcontrib>DESROY NICOLAS</creatorcontrib><creatorcontrib>PEIXOTO CHRISTOPHE</creatorcontrib><creatorcontrib>TEMAL-LAIB TAOUES</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DUTHION BERANGER</au><au>ALVEY LUKE</au><au>TIRERA AMYNATA</au><au>BONNATERRE FLORENCE</au><au>BUCHER DENIS</au><au>JARY HELENE M</au><au>DESROY NICOLAS</au><au>PEIXOTO CHRISTOPHE</au><au>TEMAL-LAIB TAOUES</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR TREATMENT OF DISEASES</title><date>2022-01-11</date><risdate>2022</risdate><abstract>The present invention discloses compounds according to Formula (I), wherein R1a, R1b, R1c, R2a, W1, W2, X1, X2, X3, Y, and Z are as defined herein. The present invention relates to compounds, methods for their production, pharmaceutical compositions comprising the same, and methods of treatment using the same, for the prophylaxis and/or treatment of inflammatory diseases, autoinflammatory diseases, autoimmune diseases, proliferative diseases, fibrotic diseases, transplantation rejection, diseases involving impairment of cartilage turnover, congenital cartilage malformation, diseases involving impairment of bone turnover, diseases associated with hypersecretion of IL-6, diseases associated with hypersecretion of TNF alpha, interferons, IL-12 and/or IL-23, respiratory diseases, endocrine and/or metabolic diseases, cardiovascular diseases, dermatological diseases, and/or abnormal angiogenesis associated diseases by administering the compound of the invention. 本发明公开了式(I)的化合物,其中R1a、R1b、R1c、R2a、W1、W2、X1、X2、X3、Y和Z如本</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_CN113924146A
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR TREATMENT OF DISEASES
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T16%3A49%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DUTHION%20BERANGER&rft.date=2022-01-11&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN113924146A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true